The short version
15 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Dextromethorphan Hbr · DEXTROMETHORPHAN HYDROBROMIDE 20 mg/100mL; GUAIFENESIN 400 mg/100mL · Liquid · Oral · Pharmadel LLC
NDC 55758-0323-06 · 177 mL in 1 BOTTLE, PLASTIC · OTC MONOGRAPH DRUG · View full market →
15 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Best Choice (Valu Merchandisers Company) | DEXTROMETHORPHAN HYDROBROMIDE 15 mg/5mL | Jul 15, 2026 | Sep 3, 2026 |
| QUALITY CHOICE (Chain Drug Marketing Association) | DEXTROMETHORPHAN HYDROBROMIDE 15 mg/5mL | Jul 15, 2026 | Sep 3, 2026 |
| Amerisource Bergen | DEXTROMETHORPHAN HYDROBROMIDE 30 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Chain Drug Consortium, LLC | DEXTROMETHORPHAN HYDROBROMIDE 30 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Cvs Pharmacy, Inc | DEXTROMETHORPHAN HYDROBROMIDE 30 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Dextrum Laboratories Inc | DEXTROMETHORPHAN HYDROBROMIDE 15 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | DEXTROMETHORPHAN HYDROBROMIDE 15 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| DXM Pharmacuetical, Inc. | DEXTROMETHORPHAN HYDROBROMIDE 30 mg/3mL | Jul 15, 2026 | Sep 2, 2026 |
| Humco Holding Group, Inc | DEXTROMETHORPHAN HYDROBROMIDE 10 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Oakhurst Company | DEXTROMETHORPHAN HYDROBROMIDE 10 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| P & L Development, LLC | DEXTROMETHORPHAN HYDROBROMIDE 30 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Pharmadel LLC | DEXTROMETHORPHAN HYDROBROMIDE 20 mg/100mL; GUAIFENESIN 400 mg/100mL | Jul 15, 2026 | Sep 2, 2026 |
| Raritan Pharmaceuticals | DEXTROMETHORPHAN HYDROBROMIDE 30 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| The Procter & Gamble Manufacturing Company | DEXTROMETHORPHAN HYDROBROMIDE 15 mg/15mL | Jul 15, 2026 | Sep 2, 2026 |
| TOP CARE (Topco Associates LLC) | DEXTROMETHORPHAN HYDROBROMIDE 15 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "SanaTos Boost — NDC 55758-0323-06," retrieved September 3, 2026, https://drugdashboards.com/drug/55758032306.
Free to cite with attribution — see how the data is put together.